Literature DB >> 1449402

Effects of cigarette smoking on motor functions in patients with multiple sclerosis.

M Emre1, C de Decker.   

Abstract

The acute effects of cigarette smoking on motor functions were examined in 21 patients with multiple sclerosis and 11 healthy control subjects. The motor function in the upper extremities was assessed by a simple test battery. Sixteen of 21 patients had a transient deterioration of their motor function immediately after smoking, lasting for 10 minutes. The mean decrease in motor performance score for all 21 patients was 14%. With the same tests performed without smoking only three of 14 patients had a deterioration and the group had a mean 8% improvement. The control group showed a steady improvement over time, both in smoking and in simulation experiments. We conclude that nicotine causes a transient worsening of motor functions in patients with multiple sclerosis, which can be due to its effects on the central nervous system or vegetative-vascular functions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1449402     DOI: 10.1001/archneur.1992.00530360041015

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  15 in total

1.  Effects of nicotine chewing gum on a real-life motor task: a kinematic analysis of handwriting movements in smokers and non-smokers.

Authors:  Oliver Tucha; Klaus W Lange
Journal:  Psychopharmacology (Berl)       Date:  2003-12-11       Impact factor: 4.530

2.  Smoking: effects on multiple sclerosis susceptibility and disease progression.

Authors:  Dean M Wingerchuk
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

3.  Smoking and disease progression in multiple sclerosis.

Authors:  Brian C Healy; Eman N Ali; Charles R G Guttmann; Tanuja Chitnis; Bonnie I Glanz; Guy Buckle; Maria Houtchens; Lynn Stazzone; Jennifer Moodie; Annika M Berger; Yang Duan; Rohit Bakshi; Samia Khoury; Howard Weiner; Alberto Ascherio
Journal:  Arch Neurol       Date:  2009-07

Review 4.  Nicotine and inflammatory neurological disorders.

Authors:  Wen-Hua Piao; Denise Campagnolo; Carlos Dayao; Ronald J Lukas; Jie Wu; Fu-Dong Shi
Journal:  Acta Pharmacol Sin       Date:  2009-05-18       Impact factor: 6.150

Review 5.  Osteoporosis and multiple sclerosis: risk factors, pathophysiology, and therapeutic interventions.

Authors:  Sahil Gupta; Irfan Ahsan; Naeem Mahfooz; Noureldin Abdelhamid; Murali Ramanathan; Bianca Weinstock-Guttman
Journal:  CNS Drugs       Date:  2014-08       Impact factor: 5.749

6.  Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis.

Authors:  R Zivadinov; B Weinstock-Guttman; K Hashmi; N Abdelrahman; M Stosic; M Dwyer; S Hussein; J Durfee; M Ramanathan
Journal:  Neurology       Date:  2009-08-18       Impact factor: 9.910

7.  Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis.

Authors:  Fotini Pittas; Anne-Louise Ponsonby; Ingrid A F van der Mei; Bruce V Taylor; Leigh Blizzard; Patricia Groom; Obioha C Ukoumunne; Terry Dwyer
Journal:  J Neurol       Date:  2009-04-09       Impact factor: 4.849

8.  The effect of smoking on the symptoms and progression of multiple sclerosis: a review.

Authors:  Afsaneh Shirani; Helen Tremlett
Journal:  J Inflamm Res       Date:  2010-09-01

Review 9.  Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis.

Authors:  Lukas Haider
Journal:  Oxid Med Cell Longev       Date:  2015-05-27       Impact factor: 6.543

10.  Humans have antibodies against a plant virus: evidence from tobacco mosaic virus.

Authors:  Ruolan Liu; Radhika A Vaishnav; Andrew M Roberts; Robert P Friedland
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.